You have 9 free searches left this month | for more free features.

selpercatinib

Showing 1 - 25 of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)

Not yet recruiting
  • Healthy
  • Dallas, Texas
    Labcorp Clinical Research LP
Jun 8, 2023

Healthy Trial in Madison ([14C] Selpercatinib, Selpercatinib)

Completed
  • Healthy
  • [14C] Selpercatinib
  • Selpercatinib
  • Madison, Wisconsin
    LabCorp CRU, Inc.
Nov 21, 2022

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Selpercatinib
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

Healthy Trial in Singapore (Selpercatinib)

Completed
  • Healthy
  • Selpercatinib
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Jul 12, 2022

Healthy Trial in United States (Selpercatinib)

Completed
  • Healthy
  • Selpercatinib
  • Anaheim, California
  • +3 more
Aug 17, 2022

Healthy Trial in Tempe (Selpercatinib, Moxifloxacin, Placebo)

Completed
  • Healthy
  • Selpercatinib
  • +2 more
  • Tempe, Arizona
    Celerion
Nov 21, 2022

Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)

Completed
  • Healthy
  • Selpercatinib
  • +2 more
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
Jan 12, 2023

Healthy Trial in Daytona Beach (Selpercatinib)

Completed
  • Healthy
  • Selpercatinib
  • Daytona Beach, Florida
    LabCorp CRU, Inc.
Apr 14, 2022

Healthy Trial in Tempe (Selpercatinib, Omeprazole)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Jul 19, 2022

Healthy Trial in Tempe (Repaglinide, Selpercatinib)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Jul 20, 2022

Healthy Trial in Tempe (Selpercatinib)

Completed
  • Healthy
  • Selpercatinib
  • Tempe, Arizona
    Celerion
Apr 19, 2022

Healthy Trial in Tempe (Midazolam, Selpercatinib)

Completed
  • Healthy
  • Tempe, Arizona
    Celerion
Apr 19, 2022

Healthy Trial in Tempe (Selpercatinib, Itraconazole, Rifampin)

Completed
  • Healthy
  • Selpercatinib
  • +2 more
  • Tempe, Arizona
    Celerion
Apr 19, 2022

Healthy, Renal Insufficiency Trial in United States (Selpercatinib)

Completed
  • Healthy
  • Renal Insufficiency
  • Selpercatinib
  • Anaheim, California
  • +5 more
Jul 20, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Selpercatinib
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Healthy, Hepatic Impairment Trial in United States (Selpercatinib)

Completed
  • Healthy
  • Hepatic Impairment
  • Selpercatinib
  • Anaheim, California
  • +6 more
Jun 24, 2022

Healthy Trial in Daytona Beach (Dabigatran, Selpercatinib)

Completed
  • Healthy
  • Daytona Beach, Florida
    Covance Clinical Research Inc
Jul 15, 2021

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

Recruiting
  • Medullary Thyroid Cancer
  • Selpercatinib
  • +2 more
  • Birmingham, Alabama
  • +148 more
Jan 18, 2023

NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Selpercatinib
  • +4 more
  • Berazategui, Buenos Aires, Argentina
  • +195 more
Jan 30, 2023

NSCLC Trial in Worldwide (Selpercatinib, Placebo)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Selpercatinib
  • Placebo
  • Santa Monica, California
  • +206 more
Dec 27, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Selpercatinib
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Selpercatinib
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022